Literature DB >> 11784881

Lung cancer--time to move on from chemotherapy.

Desmond N Carney.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 11784881     DOI： 10.1056/NEJM200201103460211

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  71 in total

1.  Lentivirus-mediated siRNA interference targeting SGO-1 inhibits human NSCLC cell growth.

Authors:  Lili Liu; Ning Zhang; Jiayu Liu; Jie Min; Ningqiang Ma; Na Liu; Yi Liu; Helong Zhang
Journal:  Tumour Biol       Date:  2011-12-08

2.  Cancer stem cell theory: pathologists' considerations and ruminations about wasting time and wrong evaluations.

Authors:  P Nuciforo; F Fraggetta
Journal:  J Clin Pathol       Date:  2004-07       Impact factor: 3.411

3.  Collagen I promotes epithelial-to-mesenchymal transition in lung cancer cells via transforming growth factor-beta signaling.

Authors:  Yasushi Shintani; Masato Maeda; Nina Chaika; Keith R Johnson; Margaret J Wheelock
Journal:  Am J Respir Cell Mol Biol       Date:  2007-08-02       Impact factor: 6.914

4.  The expression level of fibulin-2 in the circulating RNA (ctRNA) of epithelial tumor cells of peripheral blood and tumor tissue of patients with metastatic lung cancer.

Authors:  Mukaddes Avsar; Makbule Tambas; Zubeyde Yalniz; Demet Akdeniz; Seref Bugra Tuncer; Seda Kilic; Ozge Sukruoglu Erdogan; Rumeysa Ciftci; Nergiz Dagoglu; Sezai Vatansever; Hulya Yazici
Journal:  Mol Biol Rep       Date:  2019-05-08       Impact factor: 2.316

5.  Gastrin-releasing peptide receptor mediates activation of the epidermal growth factor receptor in lung cancer cells.

Authors:  Sufi Mary Thomas; Jennifer Rubin Grandis; Abbey L Wentzel; William E Gooding; Vivian Wai Yan Lui; Jill M Siegfried
Journal:  Neoplasia       Date:  2005-04       Impact factor: 5.715

6.  Astragalus-containing Chinese herbal combinations for advanced non-small-cell lung cancer: a meta-analysis of 65 clinical trials enrolling 4751 patients.

Authors:  Jean Jacques Dugoua; Ping Wu; Dugald Seely; Oghenowede Eyawo; Edward Mills
Journal:  Lung Cancer (Auckl)       Date:  2010-07-08

7.  Neoadjuvant PD-1 blockade in non-small cell lung cancer: what else do we need to do?

Authors:  Wei Guo; Su Yang; Wentian Zhang; Hecheng Li; Bo Lu
Journal:  J Thorac Dis       Date:  2018-09       Impact factor: 2.895

8.  ICAM-1 supports adhesion of human small-cell lung carcinoma to endothelial cells.

Authors:  Angela H Finzel; Armin J Reininger; Patrick A Bode; Laurenz J Wurzinger
Journal:  Clin Exp Metastasis       Date:  2004       Impact factor: 5.150

9.  Inhibition of novel protein kinase C-epsilon augments TRAIL-induced cell death in A549 lung cancer cells.

Authors:  Matthias Felber; Jürgen Sonnemann; James F Beck
Journal:  Pathol Oncol Res       Date:  2007-12-25       Impact factor: 3.201

10.  Flexible modeling improves assessment of prognostic value of C-reactive protein in advanced non-small cell lung cancer.

Authors:  B Gagnon; M Abrahamowicz; Y Xiao; M-E Beauchamp; N MacDonald; G Kasymjanova; H Kreisman; D Small
Journal:  Br J Cancer       Date:  2010-03-16       Impact factor: 7.640
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.